Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 31 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
21(84.0%)
Phase 2
2(8.0%)
Phase 3
1(4.0%)
Phase 1
1(4.0%)
25Total
N/A(21)
Phase 2(2)
Phase 3(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials
NCT07558603Not ApplicableNot Yet Recruiting

Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

Role: collaborator

NCT07556016Not ApplicableActive Not Recruiting

Evaluation of the Performance of a Nutricosmetic on Hair & Scalp in Women and Men After 3 and 6 Months

Role: lead

NCT07500649Not ApplicableRecruiting

Project SIRT6 Activator

Role: collaborator

NCT07462845Completed

Agents Effect Under Visible Light on Caucasian, Asian and Darker Skin Types

Role: lead

NCT07270965Not ApplicableNot Yet Recruiting

Moisturization and Skin Hydration Study

Role: collaborator

NCT06938815Not ApplicableCompleted

A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color

Role: collaborator

NCT06066463Suspended

My Skin & Hair Journey_virtual Registry

Role: lead

NCT07216352Not ApplicableNot Yet Recruiting

Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

Role: collaborator

NCT06945393Completed

ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHT

Role: lead

NCT06937515Completed

MELASYL EFFICACY UNDER PART OF VISIBLE LIGHT

Role: lead

NCT06813521Not ApplicableRecruiting

Antidandruff Lotion Mediating Microbiome Rebalance

Role: lead

NCT06603857Phase 2Not Yet Recruiting

Skin Care Regimen for Improving Photoaging Signs on the Face

Role: collaborator

NCT06553417Not ApplicableCompleted

Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis

Role: collaborator

NCT05937529Not ApplicableCompleted

Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis

Role: collaborator

NCT04137263Not ApplicableCompleted

Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging

Role: collaborator

NCT05506592Not ApplicableUnknown

Evaluation of the Efficacy of SeS2 Shampoo on Subjects Having Dandruff

Role: lead

NCT05503706Not ApplicableUnknown

Effects on the Scalp Lipids and TEWL of a 1% Selenium Disulfide and 1% Salicylic Acid Antidandruff Shampoo on Dandruff Scalp

Role: lead

NCT05502185Unknown

Targeting Staphylococci in Atopic Dermatitis

Role: lead

NCT04181476Phase 2Active Not Recruiting

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

Role: collaborator

NCT04866797Not ApplicableUnknown

Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure

Role: lead